• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Nephrol . Risk factors for the mortality of hemodialysis patients with COVID-19 in northern Hunan province, China

tetano

Editor, Senior Moderator
BMC Nephrol


. 2025 Jan 16;26(1):26.
doi: 10.1186/s12882-025-03946-2. Risk factors for the mortality of hemodialysis patients with COVID-19 in northern Hunan province, China

Zhangxiu He[SUP] 1 2 [/SUP], Zhong Peng[SUP] 3 [/SUP], Ning Gao[SUP] 1 [/SUP], Shuzhu Zhong[SUP] 1 2 [/SUP], Fengyi Yu[SUP] 1 3 2 [/SUP], Zixu Tang[SUP] 1 3 2 [/SUP], Zihao Liao[SUP] 1 3 2 [/SUP], Song Zhao[SUP] 1 2 [/SUP], Gloria Umwiza[SUP] 2 [/SUP], Ming Chen[SUP] 4 [/SUP], Wei Long[SUP] 5 [/SUP]



Affiliations
Abstract

Purpose: Exploring the risk factors for mortality of hemodialysis patients undergoing COVID-19 and the changes in mortality before and after the opening of the epidemic in northern Hunan province, China.
Methods: We analyzed 230 hemodialysis patients with COVID-19 in the Yiyang Central Hospital from November 01, 2022 to February 28, 2023. Demographic data, laboratory data and public diseases were collected. Cox regression analysis was used to identify risk factors and independent predictors of mortality. The receiver operating characteristic (ROC) curve was used to determine the diagnostic value of risk factors in hemodialysis COVID-19 patients.
Results: The average duration of the disease was 12.53 days. The mortality rate in our cohort was 28.70%. Independent predictors of mortality in our cohort were: age (hazard ratio
1.09; 95% confidence interval [CI], 1.05-1.14; P < 0.001), elevated procalcitonin (PCT) levels (HR 1.02; 95%CI, 1.01-1.03; P < 0.001), and higher white blood cell-neutrophil ratio (NWR) (HR 1.04; 95%CI, 1.04-1.07; P = 0.004). Areas under the ROC curve (AUC) for age, NWR, PCT, age*NWR were 0.70 (95%CI: 0.62-0.77), 0.82 (95%CI: 0.75-0.90), 0.64 (95%CI: 0.55-0.73), and 0.89 (0.85,0.94).
Conclusion: We discovered that old age, high levels of NWR and PCT might be predictors of mortality, reported the causes and prognostic predictors of mortality in hemodialysis populations with COVID-19 from northern Hunan, China.

Keywords: COVID-19; Hemodialysis; Mortality; Prognosis.

 
Back
Top Bottom